Elanco Animal Health (ELAN) Revenue (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Revenue data on file, last reported at $1.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 14.92% year-over-year to $1.4 billion; the trailing twelve-month figure through Mar 2026 stood at $4.9 billion (up 10.53% YoY), and the FY2025 full-year result was $4.7 billion, up 6.22% from the prior year.
• Revenue climbed to $1.4 billion in Q1 2026, from $1.1 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.4 billion in Q1 2026 to a low of $985.0 million in Q4 2022.
• A 5-year average of $1.1 billion and a median of $1.1 billion in 2025 frame the typical range for Revenue.
• Across the five-year window, Revenue retreated 11.42% in 2022 and climbed 14.92% in 2026, its largest moves.
• Tracing ELAN's Revenue over 5 years: stood at $985.0 million in 2022, then increased by 5.08% to $1.0 billion in 2023, then retreated by 1.45% to $1.0 billion in 2024, then advanced by 12.16% to $1.1 billion in 2025, then advanced by 19.84% to $1.4 billion in 2026.
• Business Quant data shows ELAN's Revenue at $1.4 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.